Tower Research Capital (TRC)’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Tower Research Capital (TRC)’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-185	Closed	-$3.12K	–	6493
2023 Q2	$3.12K	Sell	185 -92	-33%	-$1.21K	﹤0.01%	5110
2023 Q1	$2K	Buy	+277	New	+$2.28K	﹤0.01%	5457
2021 Q4	–	Sell	-1,024	Closed	-$8K	–	6792
2021 Q3	$8K	Buy	1,024 +678	+196%	+$5.81K	﹤0.01%	4590
2021 Q2	$4K	Buy	+346	New	+$5.25K	﹤0.01%	4856

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return

Tower Research Capital (TRC)'s VECT Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 185 shares — an estimated $3.12K sold.

Tower Research Capital (TRC) first reported a position in VECT in Q2 2021 and held it in 4 quarters. The position peaked at $8K in Q3 2021. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Tower Research Capital (TRC) reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 185 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $3.12K.
Tower Research Capital (TRC) first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 4 quarters.
Tower Research Capital (TRC)'s VectivBio Holding AG Ordinary Shares position peaked at $8K in Q3 2021.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.